Clinical Trial Update: Miltefosine for Mucosal Leishmaniasis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating miltefosine for mucosal leishmaniasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leishmaniasis
• Mucosal Leishmaniasis

Drugs mentioned

• Miltefosine (miltefosine)

Snippet

Sponsor: AB Foundation | Conditions: Leishmaniasis | Phase 1, Phase 2 | Status: COMPLETED